Related Experiment Videos
Hybridization and cell uptake studies with radiolabelled antisense oligonucleotides
1ICRF Nuclear Medicine Research Laboratory, St Bartholomew's Hospital, London, UK.
Nuclear Medicine Communications
|October 19, 2001
Summary
Radiolabelled antisense oligonucleotides show promise for gene expression imaging but face challenges. Cell membrane and intracellular barriers may limit their effectiveness as radiopharmaceutical vectors in vivo.
Area of Science:
- Molecular Biology
- Radiochemistry
- Gene Expression Profiling
Background:
- Antisense oligonucleotides (ASOs) are investigated as radiopharmaceuticals for in vivo gene expression imaging.
- This study evaluates the cellular uptake of radiolabelled ASOs in cell lines with varying target mRNA levels.
Purpose of the Study:
- To assess the efficacy of radiolabelled oligonucleotides in targeting specific mRNA in cellular models.
- To determine if cellular uptake is influenced by the expression level of the target gene.
Main Methods:
- A 15-mer antisense oligonucleotide targeting c-myc mRNA was radiolabelled with 99mTc and 32P.
- In vitro hybridization and stability assays were conducted.
- Cellular uptake studies utilized a c-myc expressing cell line (TGR-1) and a c-myc knock-out cell line (HO15.19).
Main Results:
- Efficient radiolabelling was achieved, and the oligonucleotides maintained mRNA hybridization capability post-extraction.
- Radiolabelled oligonucleotides demonstrated stability in human serum for several hours.
- No significant difference in radioactivity uptake was observed between the two cell lines.
Conclusions:
- Radiolabelled oligonucleotides can bind target mRNA effectively in cell-free systems.
- Cell membrane penetration and intracellular metabolism may impede the in vivo application of these molecules as radiopharmaceutical vectors.